Clinical Trials
Study Title:
A Phase 1b Study of ASP1951, a GITR Agonistic Antibody, as a Single Agent and in Combination with Pembrolizumab in Subjects with Advanced Solid Tumors
|
For more information about the trial above please contact the study team:
|